Albany, NY -- (SBWIRE) -- 12/19/2016 -- Microencapsulation has been recognized as a rather promising technique when it comes to controlled drug delivery. As drug delivery systems, microparticles offer a wide range of significant benefits such as providing desired and pre-programmed drug release profiles that are in line with the needs of the patient, effectively protecting the encapsulated active agent against degradation, easy administration of drugs, and the possibility of controlling the drug release rate over short and long periods. Given the advantages and recent advances in the field, the efficiency of various medical treatments has improved, thereby giving the microencapsulation market a remarkable boost.

The technology of microencapsulation is not restricted to pharmaceuticals alone. In fact, industries such as household products, agrochemicals, industrial chemicals, and functional foods and food additives have also benefited from microencapsulation to a great extent. One of the most significant advantages that this technology brings to the end-use industries is lower cost of production. By employing microencapsulation technology, the quantity of raw materials needed for the manufacture of a final product can be monitored and reduced, thereby lowering the overall cost of manufacture.

Get Free PDF Research Brochure for more Professional and Technical Insights: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1671

Industry-wise Benefits of Microencapsulation

Pharmaceuticals

Among the major application segments, the employment of microencapsulation in pharmaceuticals dominated the global market in 2013, accounting for more than 65% of the total market. Microencapsulation in pharmaceuticals helps in achieving the targeted drug delivery, allows for sustained release of drugs over a long period of time, masks chemical odors, and increases the bioavailability of drug molecules. The pharmaceutical industry around the globe has been witnessing immense growth for several years and this is expected to fuel the demand for microencapsulation.

The North America and Europe markets for microencapsulation are the leading regional segments primarily due to the presence of a progressive and highly advanced pharmaceutical industry. The treatment of genetic disorders by means of targeted DNA delivery has stimulated the use of microencapsulation in biotechnological research in these regions. In 2013, Europe and North America together held over 70% of the global microencapsulation market. The rapid development of medical and pharmaceutical infrastructure and research in developing countries of Asia Pacific is expected to drive the usage of microencapsulation over the next few years.

Household Products and Functional Foods

The adoption of microencapsulation technology in household products and functional foods has grown in recent times. By microencapsulating prebiotics, nutrients, preservatives, dietary supplements, and food enzymes, the texture, taste, and nutrient content of food products is enhanced and the overall shelf life is also improved. Microencapsulation of active ingredients such as optical brighteners, antimicrobial agents, and fragrances in cleaning agents and detergents increases the quality of the product, thereby driving the microencapsulation market.

The demand for and acceptance of functional food additives and household products among consumers in North America and Europe has resulted in an increasing share of the global microencapsulation market for these two regional segments. However, with more and more consumers realizing the benefits of the technology in emerging economies, the market for microencapsulation in Asia Pacific is poised to grow at a strong pace. This trend is greatly supported by the rise in purchasing power, change in dietary and retail preferences, and increasing awareness regarding personal health and wellbeing. As a result, the Asia Pacific market for microencapsulation is projected to develop at a 10.5% CAGR from 2014 to 2020.

Browse Full Global Microencapsulation Market Research Report With Complete TOC: http://www.transparencymarketresearch.com/microencapsulation-market.html

As mentioned earlier, the adoption of microencapsulation in several end-use industries has allowed companies to minimize production cost. Consequently, an increasing number of players offer customized microencapsulation solutions in order to enhance their share in the market. Some of the leading players that employ this technology are Bayer AG, Aveka, Inc., Dow Corning Corporation, Ronald T. Dodge Company, Capsulae, Lipo Technologies, Balchem Corporation, Reed Pacific, BASF S.E., Encapsys, Microtek Laboratories, Inc., Evonik Industries AG, GAT Microencapsulation GmbH, Taste Tech Ltd., and 3M.

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.